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ABSTRACT
Gelatinous transformation of the bone marrow (GTBM) is a rare hematologic entity, which was first described by Paul 
Michael in 1930. GTBM is mostly associated with caloric intake/anorexia nervosa, although it also has been described 
accompanying other pathologic conditions, such as malignancy, systemic lupus erythematosus and HIV infections. 
Even though the diagnostic features of the hematopoietic tissue, such as hypoplasia, adipose cell atrophy, and deposition 
of a gelatinous substance in the bone marrow (which stains with Alcian blue at pH 2.5) are quite specific, the underlying 
pathogenic mechanisms remain poorly understood. Considering the evidence of reversibility—notably in cases of 
malnutrition and anorexia—this entity should be kept high on cards as a possible differential diagnosis of patients 
presenting with cytopenias and associated weight loss or starvation, especially in developing countries with nutritionally 
deprived populations. On an extensive review of the literature aimed at comprehensively addressing the evolution of 
the GTBM from the past century until now, we conclude that the lack of clinical suspicion and awareness regarding this 
pathologic entity has led to misdiagnosis and delayed diagnosis. 
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INTRODUCTION
Gelatinous transformation of bone marrow 
(GTBM)—also known as starvation marrow—
gelatinous degeneration and serous atrophy of 
bone marrow is a well-defined hematologic entity.1,2 
Although the first references were noticed in works 
of Virchow (1821–1902), Herter (1865–1910), and 
Adami (1862–1926), it was Paul Michael, in 1930, 
who first reported 11 cases of GTBM in the bone 
marrow of autopsied cases.1 A large number of 
studies published at the end of the 20th century 
worldwide, considered GTBM as a histologic pattern 
originating from an associated cause rather than 
being a disease entity by itself.3
In fact, GTBM has been described in association 
with a variety of clinical scenarios, chiefly in the young 
with malnourishment and anorexia.3,4 In cases with 
high clinical suspicion, the diagnosis can be easily 
established by studying the bone marrow aspirate or 
bone biopsy with Alcian blue staining at pH 2.5, which 
loses positivity after pre-treatment with hyaluronidase.3 
The reported rare incidence of GTBM might just be the 
tip of the iceberg, with the lack of clinical suspicion 
being the most probable culprit for so few diagnoses.
This review was undertaken to study the 
epidemiological behavior and incidence of GTBM 
reports over the years while focusing on clinical 
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profiles, hematologic parameters and investigations, 
and proposed pathogenic mechanism.
MATERIAL AND METHODS
In our pre-specified protocol, we used the 
keywords “gelatinous transformation/degeneration 
of the bone marrow, starvation marrow, and serous 
atrophy of the marrow” to identify the target papers 
for a systematic literature search. The databases, 
PubMed, Medline, Google Scholar and Research Gate, 
were accessed to retrieve the articles published until 
June 2017.
Case and series reports, original research articles, 
images, letters to editors with titles having the 
aforementioned keywords were included in the study. 
Data including the first author’s last name, publication 
year, country of origin and total number of cases 
reported in each study was compiled. All open access 
articles and abstracts of subscribed articles were 
included in the study.
Articles published in a language other than 
English for which no translation or English abstract 
was available, were excluded.
All articles fulfilling inclusion criteria were 
reviewed in duplicate and independently, and data 
extraction was held by two authors (KKS & GSS).
All articles were assessed for following variables: 
total number of studies published with total number 
of cases; clinical profile including age, sex and the 
associated disease; altered hematological indices; 
diagnostic work-up modality (cytological and/or 
histologic parameters of bone marrow); reversal 
or improvement with treatment; and additional 
information reported with respect to the pathogenesis 
of GTBM by the different authors.
Data were compiled in chronological order 
(decade wise); however, no quantitative data synthesis 
or statistical analysis could be performed due to 
considerable clinical and mathematical heterogeneity 
of the compiled data.
RESULTS
Our literature search gathered 79 papers (N) with 
relevant titles, amounting the total of 522 reported 
cases (n) as shown in Table 1. Of these 79 papers, 
66 were in the English language while 13 were in 
other languages, such as French, German, Dutch, and 
Polish. Of these 13 studies, 4 had an English language 
abstract. Hence the remaining 09 articles (n = 26) were 
excluded.
A final list of 70 titles was compiled, which 
comprised 48 full articles (n = 394) and only 22 Abstracts 
(n = 102). Out of these, 48 open access articles were 
subjected to review by two authors independently and 
the remaining 22 subscribed articles only with abstracts 
were reviewed for available data.
We observed that the research articles on GTBM, 
which constituted the bulk of cases, had limited 
information on the parameters of the individual cases. 
Hence, the scope for statistical analysis of data was 
limited. However, an overall trend was established 
based on the available data.
Incidence of Gelatinous Transformation of Bone 
Marrow Over the Last Century
The first available published study on GTBM by 
Paul Michael (1930) comprised a total of 11 cases.1 
Over the following three decades, no published data 
were available. In 1967, a study by Pearson5 surfaced, 
reporting GTBM in three cases of anorexia nervosa. 
In the subsequent decade; two more studies were 
published by Tavassoli et al.6 (1976) and Seamen et al.2 
(1978) who described the condition in 9 and 14 cases, 
respectively. In the 1980s, six more studies were 
published, describing the condition in seven different 
patients. However, no open access article could be 
found on a literature search of the archives till 1990.7-12 
The number of studies tripled (N = 18) in the 1990s 
with a total of 52 cases reported,13-30 including one 
original research article by Mehta et al.16 who described 
the condition in 22 patients with HIV—the first ever 
study from India—by Ray et al.17 in 1992, and another 
one by Basu et al.26 At the dawn of the 21st century, a 
deluge of research articles on GTBM were published. 
Among them, 21 new studies appeared in the first 
decade itself, including the largest study by Bohm3 
(2000) who studied 80,000 bone marrow samples and 
reported the GTBM incidence of 0.2%.3,4,31-49 In the 
last 7 years, 30 new studies comprising 117 cases 
were published.50-79 Thus, a total of 79 studies with 
522 individual cases of GTBM have been published in 
the last 87 years (Table 1). These data clearly indicate 
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a rising trend in reporting the condition, especially in 
the last two decades.
Clinical Profiles
Our analysis showed a total of 236 male patients 
compared to 160 females with a M:F ratio of 1.5:1. 
Cases were divided into four age groups: <15 years, 
16-40 years, 41-60 years and >60 years. In the initial 
studies, the most commonly involved age group was 
40-60 years and >60 years with an occasional case in 
the <15 years age group. However, with more cases of 
young patients being reported in the past two decades, 
a total of 143 cases were noted in the age group of 
15-40 years, followed by the elderly age group of 
>60 years (103).
In our analysis, a total of 70 cases were seen in 
the <15 years age group (Table 1). The most common 
reported etiologies associated with GTBM were 
anorexia nervosa, and malnutrition or malabsorption 
with weight loss (47 cases). Similarly, the majority of 
cases, reported by Jain et al.4 (the largest case series 
from India), also concluded that malnutrition is the 
most common condition associated with GTBM. Further 
GTBM associated with malignancy was reported in 
109 cases and comprised several types of cancers, such 
as hepatocellular carcinoma,64 oral cancers,74 along 
with primary malignancies of the bone marrow, such as 
acute myeloid leukemia (AML),14 and chronic myeloid 
leukemia (CML)47. Another 60 cases were associated 
with different types of infective agents excluding 
those reported in HIV patients.16 A total of 17 cases of 
aplastic anemia with GTBM were reported in study by 
Sen et al.37 As in cases of malignancy, HIV infection and 
chronic infections, like tuberculosis, where weight loss 
is quite often an associated complaint, there seems to 
be an overlap leading to an underestimation of cases 
of GTBM associated with anorexia and malnutrition. 
A total of 40 cases were labeled as miscellaneous, 
which comprised different associated diseases, 
such as systemic lupus erythematosus,15,49 visceral 
Leishmaniasis,17 hemochromatosis;48 and metabolic 
abnormalities, such as hyperthyroidism, adrenal 
insuffiency,74 pyrexia of unknown origin, and alcoholic 
pancreatitis have also been published.
Investigations
The most common altered laboratory parameter 
found in the majority of the cases was the presence 
of at least one peripheral cytopenia. In this setting, 
anemia was the most common. In some of the larger 
series, almost 100% of the cases were reported 
to have anaemia.4,16,37,63 Pancytopenia as the initial 
presentation was present in 22 cases.58,64,65,68,70,73 
However, cytopenias were occasionally lacking,41,71 
and a single case of myelofibrosis, accompanied by 
GTBM, had leukocytosis along with thrombocytosis.31
In all cases, the diagnosis was initially achieved 
either on a bone marrow aspirate or bone marrow 
biopsy; however, the bone marrow biopsy was 
reported to be the method of choice mainly in 
cases with a dry tap on bone marrow aspiration.3,63 
Histological examination was characterized by different 
patterns of bone marrow cellularity, varying from 
hypocellularity to normocellularity—or even cases 
of hypercellularity with focal areas of hypocellularity 
surrounding the gelatinous deposits.31,63,65,66 Böhm3 
graded the bone marrows from 1 to 4 based on the 
severity of gelatinous transformation.
Bone marrows were stained with Alcian blue at 
pH 2.5 along with routine H&E stains and additional 
stains like Congo Red, and periodic acid–Schiff to rule 
out other differential diagnoses.
Prognosis
Pearson5 and Tavassoli et al.6 firstly reported 
the reversibility of GTBM on animal experiments. 
In our review, we found 35 cases that showed the 
disappearance of the GTBM on follow-up on repeated 
biopsy/aspirate after the initiation of treatment, 
which was either in the form of nutritional diet 
(15 cases),58,60,62,66 packed red blood cell (PRBCs) 
transfusion (one case),57 granulocyte colony stimulating 
factor (G-CSFs) (three cases)51 or treatment of the 
underlying disease.
DISCUSSION
Since 1930, there has been an increasing number 
of reported cases of GTBM. From the advent of the 
21st century, more than 50 studies were published 
accounting for more than 400 new cases (Table 1). 
The majority of these cases were from countries 
like India where GTBM was unheard of before the 
1990s. The reported incidence of GTBM varies from 
0.2%,3 to 4.4%37 and 4.8%.66 This rising trend in its 
incidence over the years indicates that GTBM, in the 
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current scenario, is anything but rare. On review of the 
literature, Seaman et al.2 seems to aptly describe GTBM 
as “Not uncommon,” whereas the majority of studies 
continue to report it as “a rare condition.” Based 
on our analysis, we conclude that the low incidence 
observed in the 20th century can be ascribed to the 
lack of awareness about the existence of such an entity.
Overall, there is a male preponderance in the 
cases reported so far.3,37 However, in certain studies, 
like Abella et al.,36 all 22 cases reported were females 
while in study by Mehta et al;16 86% cases were males. 
This may probably be due to a selection bias in such 
studies. Young adults and the elderly constitute the 
most commonly affected age;3 however, there has 
been an increase in the number of cases reported in 
the pediatric age group over last two decades, most 
of which have been reported from India.4,37,65 Hence, 
it is noteworthy that no age group is immune to the 
condition, and thus GTBM should not be neglected as 
a differential diagnosis in any age group.
The underlying disease spectrum associated 
with GTBM is heterogeneous. The most common 
associat ion had been reported with cases of 
malnourishment/starvation resulting from various 
causes like anorexia, chronic infections, or malignancy.1 
Though most of the initial case reports were associated 
with non-hematopoietic malignancies, recently 
GTBM has been reported in association with various 
hematopoietic malignancies like AML,14,18,25 acute 
promyelocytic leukemia (APML) on All Trans Retinoic 
Acid,70 acute lymphocytic leukemia (with and without 
dasatinib),61,63 CML on imatinib,47,55,56,72 CML in 
chronic phase,50 myelodysplastic syndrome,45,59 
multiple myeloma33and myelofibrosis,31 which also 
have been published from all over the world. In many 
of these cases, marked weight loss with anorexia 
was present,44,63,74,77 thus pointing to the possibility 
that the underlying mechanism resulting in the 
development of GTBM remains the same as in the 
cases of chronic infections and malignancies, anorexia, 
and malnutrition.
A remarkable number of patients had bi- or 
pancytopenia at the initial presentation, and almost 
all had anemia, irrespective of the underlying 
associated disease. Even though no correlation 
between the severity of GTBM and the peripheral 
hematological parameters have been reported,3,63 it 
still should be kept in the differential diagnosis of 
cytopenias. Regarding the investigation modality, 
bone marrow biopsy appears to be the gold standard, 
and it appears preferable to perform trephine biopsy 
along with aspirate in suspected cases rather than 
doing aspirate alone. In 2010, Sims80 described the 
characteristic findings of patchy areas of hyperintensity 
in T2-weighted images in cases of GTBM detected by 
magnetic resonance imaging (MRI). However, there 
are cases of GTBM misdiagnosed as spinal tumours32 
or misinterpreted as technical errors on MRI.75
The diagnosis is easily achieved in bone marrow 
biopsy, which exhibits the features of hematopoietic 
hypoplasia, adipose cell atrophy, and the deposition 
of gelatinous substance in bone marrow that stains 
with Alcian blue at pH 2.5 (Figure 1).1,3,6 However, 
a large number of cases present normocellular or 
hypercellular marrows or focal areas of hypocellularity 
surrounding the gelatinous substance, which easily can 
be misinterpreted as bone marrow edema, necrosis, 
or amyloid. The misinterpretation occurs with a lack 
of suspicion or knowledge of this entity. (Table 2).3,69 
Recently, GTBM post-chemotherapy has been reported 
without fat atrophy.18,33 Although the pathogenesis 
of GTBM remains unknown, the majority of the 
studies, especially in cases of nutritional deprivation, 
agree upon a common pathophysiologic mechanism 
of fat mobilization in the face of starvation followed 
by the deposition of hyaluronic acid.This excessive 
accumulation of extracellular gelatinous material 
interferes with the hematopoietic microenvironment 
leading to the suppression of hematopoiesis, which is 
reflected as peripheral blood cytopenias.51,59
In GTBM associated with infectious diseases, 
as in HIV infection, the secretion of cytokines, such 
as interleukin (IL)-1, IL-2, and the tumor necrosis 
factor, are considered to be the driving factors.43 
Similarly, it may hold true for the cases associated with 
malignancy. Alternate theory suggests that the tumor 
cells may play a role in the initiation of hyaluronic 
acid formation.11 In the cases of GTBM following 
chemotherapy, the inhibition of tyrosine kinase activity 
leads to the blockage of downstream signal pathways 
affecting extracellular matrix deposition, and adipocyte 
differentiation has been proposed as the possible 
mechanism.72 Local milieu factors of the marrow as 
the systemic “stress factors” have been proposed as 
the inciting factors for the development of GTBM in 
cases associated with aplastic anaemia.37
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Long-term outcomes and the prognosis of GTBM 
have not been well documented yet. A few authors 
have stated that GTBM, by itself, does not have any 
prognostic significance, and that the survival of patients 
who develop GTBM is dependent on the nature and 
stage of the underlying disease at the time of the 
diagnosis.3,18,37,70,81 However, with the increasing 
number of case reports showing an improvement of the 
GTBM in patients after balanced nutrition,81 PRBCs,57, 
G-CSFs,51 erythropoietin,58 the irreversibility of GTBM 
has been questioned. Mant and Faragher81 reported 
that GTBM is a temporary condition, which reverses 
on balanced nutrition in cases of anorexia nervosa. 
The timely diagnosis and early treatment in such 
cases would reduce the costs of long-term health care 
expenses,51 especially in developing countries, like India.
Figure 1. Photomicrography of the bone marrow. A – marked hypocellularity of the hematopoietic cells and scant 
fat tissue immersed in an amorphous eosinophilic material (H&E, 200X); B – this stains blue with Alcian blue staining 
(200X). This is consistent with the diagnosis of gelatinous transformation of the bone marrow in an autopsy case 
of a severely malnourished corpse (Figures provided by Dr. Aloísio Felipe-Silva, MD, PhD; chief of the Anatomic 
Pathology Service, Hospital Universitário, University of São Paulo).
Table 2. Differential diagnosis of GTBM
Bone Marrow GTBM
Marrow  
Necrosis
Marrow  
Edema
Amyloid
Aplastic  
Anemia
Microscopy Extracellular 
eosinophilic 
amorphous 
material with 
fibrinous 
precipitate.
Inverse 
relationship with 
fat vacuoles.
Vacuole outlines 
prominent, 
ragged and 
irregular.
Diffuse hypoplasia 
to only focal 
hypoplasia with 
surrounding areas 
showing normal 
cellularity
Eosinophilic 
granular material 
with the presence 
of cellular 
karyorrhectic 
debris
Hypocellular 
marrow areas 
with fat cells of 
normal size and in 
normal quantity
Homogenous 
pink material in 
the vessel wall, 
or interstitial 
with intact fat 
vacuoles.
There is an 
increase in plasma 
cells
Loss of myeloid 
tissue without any 
fat cell atrophy
Congo Red - - - +++
Alcian blue pH 2.5 +++ (Stains blue) - - - -
PAS Stains pink - Pale pink -
GTBM = gelatinous transformation of bone marrow; PAS = periodic acid–Schiff.
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CONCLUSION
From an extensive review of the literature, 
we conclude that GTBM is a condition that is 
underdiagnosed because of the lack of clinical 
suspicion. Though large-scale prospective studies 
are required to establish the pathogenesis, GTBM 
should be considered as a differential diagnosis in all 
cases presenting with weight loss, malnutrition, and 
refractory peripheral cytopenias—irrespective of age 
profile and associated co-morbidities.
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